Related Experiment Videos
Drug acetylation in breast cancer
D J Webster1, D Flook, J Jenkins
1Department of Surgery, University of Wales College of Medicine, Llandough Hospital, Penarth, South Glamorgan, UK.
British Journal of Cancer
|August 1, 1989
Abstract:
The acetylator phenotype was determined in 100 patients with breast cancer and 100 control female subjects using isoniazid. The proportion of fast acetylators in the breast cancer patients (43%) was not significantly different from the control group (43%). We conclude that acetylator phenotype is unlikely to be an important determinant of the risk of developing breast cancer.